Aera Therapeutics, a biotechnology company harnessing next-generation enabling delivery technologies and precision payloads to unlock the full potential of genetic medicines, today presented ...
New preclinical data demonstrate deeper IgA reduction and a longer half-life compared to first-generation anti-APRIL ...
Bio-Techne Corporation TECH recently announced new advancements in its spatial biology portfolio for the RNAscope ISH ...
Genmab acquires Merus for $8bn, adding promising oncology asset petosemtamab. Check out my thoughts on this deal and my ...
Dr Maja Petkovic commented “The first FDA approved treatments were CAR-T cells directed against the B cell protein CD19. This ...
The News-Times on MSN
Builder’s plan to add 12 homes to gated community near Danbury High School gets environmental review
The proposed area of development consists of a relatively flat, partially cleared ridgetop with steeper, wooded side slopes ...
TipRanks on MSN
Climb Bio Unveils Promising Preclinical Data for CLYM116
Climb Bio ( ($CLYM) ) has issued an announcement. On September 29, 2025, Climb Bio announced new preclinical data for CLYM116, a monoclonal ...
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today ...
Scientists have engineered Salmonella bacteria to self-destruct inside tumors, releasing signals that spark powerful immune ...
The ACR recently issued the first formal international consensus guidance statement on diagnosing and managing VEXAS syndrome.
8h
BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce today that the Company and ...
Early voting has started across Seychelles as concerns over a drug crisis and environmental challenges facing the nation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback